tradmap

RAPP Earnings Rapport Therapeutics, Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$23 -$12 $0 2023 2024 2025
EPS
Net income (annual)
-$111M -$56M $0 2023 2024 2025
Net income
Return on equity (annual)
-26% 55% 136% 0% 2023 2024 2025
ROE

Quarterly results

Diluted EPS (quarterly)
-$15 -$7 $0 Q2 '23 Q3 '23 Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26
EPS
Revenue (quarterly)
$0 $10M $20M Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Revenue
Net income (quarterly)
-$57M -$28M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income

Reported EPS history

1–13 of 13
Q2 20262026-06-30-1.612026-08-0510-Q
Q1 20262026-03-31-0.422026-05-0710-Q
FY 20252025-12-31-2.862026-03-1010-K
Q3 20252025-09-30-2.152025-11-0610-Q
Q2 20262025-06-30-1.442026-08-0510-Q
Q1 20262025-03-31-0.682026-05-0710-Q
FY 20252024-12-31-3.782026-03-1010-K
Q3 20252024-09-30-3.662025-11-0610-Q
Q2 20252024-06-30-6.422025-08-0710-Q
Q1 20252024-03-31-11.072025-05-0810-Q
FY 20242023-12-31-23.102025-03-1110-K
Q3 20242023-09-30-14.722024-11-0710-Q
Q2 20242023-06-30-8.962024-08-0810-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.